We are live on ! Find out more
CRC

Curi RMB Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 18.93%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+18.93%
3 Year Est. Return
+60.65%
5 Year Est. Return
+73.12%
10 Year Est. Return
+312.51%
AUM
$4.17B
AUM Growth
-$194M
Cap. Flow
-$171M
Cap. Flow %
-4.1%
Top 10 Hldgs %
18.88%
Holding
577
New
17
Increased
140
Reduced
287
Closed
51

Top Buys

Rank Stock Value
1
VRSK icon
Verisk Analytics
VRSK
+$23.2M
2
MSFT icon
Microsoft
MSFT
+$19.5M
3
IEX icon
IDEX
IEX
+$10.7M
4
PM icon
Philip Morris
PM
+$6.74M
5
ZTS icon
Zoetis
ZTS
+$6.45M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Financials 15.71%
3 Healthcare 11.87%
4 Industrials 9.59%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DT icon
251
Dynatrace
DT
$14.8B
$2.28M 0.05%
51,051
+3,235
+7% +$149K
OSBC icon
252
Old Second Bancorp
OSBC
$1.32B
$2.22M 0.05%
150,000
HON icon
253
Honeywell
HON
$78.6B
$2.21M 0.05%
10,966
-3,950
-26% -$752K
PRU icon
254
Prudential Financial
PRU
$41.7B
$2.21M 0.05%
18,825
+8
+0% +$923
RS icon
255
Reliance Steel & Aluminium
RS
$21.5B
$2.14M 0.05%
7,482
+2
+0% +$602
EPD icon
256
Enterprise Products Partners
EPD
$81.6B
$2.13M 0.05%
73,489
-27,100
-27% -$777K
DVY icon
257
iShares Select Dividend ETF
DVY
$23.5B
$2.13M 0.05%
17,590
+67
+0.4% +$8.13K
ARE icon
258
Alexandria Real Estate Equities
ARE
$8.73B
$2.12M 0.05%
18,107
+354
+2% +$42.2K
CRSP icon
259
CRISPR Therapeutics
CRSP
$5.17B
$2.11M 0.05%
39,118
+4,804
+14% +$278K
FAST icon
260
Fastenal
FAST
$57.4B
$2.1M 0.05%
66,770
-28
-0% -$945
FROG icon
261
JFrog
FROG
$10.2B
$2.05M 0.05%
54,727
ISRG icon
262
Intuitive Surgical
ISRG
$133B
$1.99M 0.05%
4,474
+72
+2% +$28.7K
QCOM icon
263
Qualcomm
QCOM
$165B
$1.96M 0.05%
9,846
-63
-0.6% -$11.9K
SSB icon
264
SouthState Bank Corp
SSB
$10.6B
$1.93M 0.05%
25,262
-12,168
-33% -$942K
AVGO icon
265
Broadcom
AVGO
$1.99T
$1.91M 0.05%
11,880
-5,950
-33% -$834K
NVO
266
Novo Nordisk
NVO
$197B
$1.9M 0.05%
13,288
+1,685
+15% +$223K
QTWO icon
267
Q2 Holdings
QTWO
$3.97B
$1.89M 0.05%
31,395
WFC.PRL icon
268
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.67B
$1.89M 0.05%
1,593
+483
+44% +$568K
SLQD icon
269
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
$1.86M 0.04%
37,670
-3,514
-9% -$172K
HEI.A icon
270
HEICO Corp Class A
HEI.A
$37.2B
$1.85M 0.04%
10,400
CCB icon
271
Coastal Financial
CCB
$675M
$1.85M 0.04%
40,000
-60,000
-60% -$2.52M
GBTC icon
272
Grayscale Bitcoin Trust
GBTC
$9.74B
$1.84M 0.04%
38,168
-497
-1% -$26.2K
CAT icon
273
Caterpillar
CAT
$401B
$1.77M 0.04%
5,299
-185
-3% -$64.1K
SHBI icon
274
Shore Bancshares
SHBI
$814M
$1.76M 0.04%
153,973
-21,027
-12% -$228K
LOB icon
275
Live Oak Bancshares
LOB
$2.03B
$1.75M 0.04%
50,000
-25,000
-33% -$885K

Similar funds

Curi RMB Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Curi RMB Capital held 577 positions worth $4.17B, down 4.4% from $4.36B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Curi RMB Capital withdrew a net $171M in Q2 2024, closing 51 positions and reducing 287 holdings. Its most notable exit was Teledyne Technologies, an estimated $3.74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Curi RMB Capital opened a new position in Abacus Global Management worth $4.65M.

  • Curi RMB Capital's largest Q2 2024 buy was Abacus Global Management: 537,235 shares worth $4.65M.
  • Curi RMB Capital added most to Verisk Analytics in Q2 2024, an estimated $23.2M increase.
  • Curi RMB Capital's biggest Q2 2024 reduction was Fortune Brands Innovations, cutting an estimated $20.8M.
  • Curi RMB Capital fully exited Teledyne Technologies in Q2 2024, selling an estimated $3.74M.
  • Curi RMB Capital's ten largest holdings make up 19% of its $4.17B portfolio in Q2 2024.
  • Curi RMB Capital opened 17 new positions and closed 51 in Q2 2024.
  • Curi RMB Capital's portfolio value fell 4.4% quarter-over-quarter to $4.17B.

Based on Curi RMB Capital's 13F filing for Q2 2024, filed 13 Aug 2024.